(IBDX) Trust - iBonds Dec 2032 - Overview

ETF Category: Target Maturity | Exchange: NYSE ARCA (USA) | Market Cap: 1.669m USD | Total Return: 5.9% in 12m

Corporate Bonds, Fixed Income, Investment Grade
Total Rating 35
Safety 66
Buy Signal -0.25
Target Maturity
Category Rotation: +6.7
TER: 0.10%
AUM: 1.67B
Avg Turnover: 4.61M
Risk 3d forecast
Volatility4.31%
VaR 5th Pctl0.79%
VaR vs Median1.99%
Reward TTM
Sharpe Ratio0.42
Rel. Str. IBD30.3
Rel. Str. Peer Group33.3
Character TTM
Beta0.119
Beta Downside0.081
Hurst Exponent0.568
Drawdowns 3y
Max DD7.09%
CAGR/Max DD0.86
CAGR/Mean DD4.38

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: IBDX Trust - iBonds Dec 2032

IBDX is a target-maturity exchange-traded fund designed to track an index of investment-grade corporate bonds maturing in 2032. The fund maintains a mandate to invest at least 80% of its assets in index components and 90% in representative fixed-income securities, including exposure to non-U.S. issuers as required by the underlying benchmark.

The target-maturity structure differs from traditional bond ETFs by returning capital to shareholders upon the funds liquidation date, effectively mimicking the behavior of an individual bond. This model allows investors to manage interest rate risk and build precise bond ladders to meet future cash flow requirements. For deeper insights into the credit quality of these holdings, consider reviewing the detailed analytics on ValueRay.

Headlines to Watch Out For
  • Investment grade corporate credit spreads impact net asset value performance
  • Federal Reserve interest rate policy shifts influence underlying bond valuations
  • Corporate default rates among 2032 maturity debt affect fund yield
  • Secondary market liquidity for term-specific corporate bonds determines tracking error
  • Market demand for defined-maturity bond ladders drives fund net inflows
What is the price of IBDX shares?

As of June 04, 2026, the stock is trading at USD 25.07 with a total of 252,165 shares traded.
Over the past week, the price has changed by -0.04%, over one month by +0.16%, over three months by -1.04% and over the past year by +5.94%.

Is IBDX a buy, sell or hold?

Trust - iBonds Dec 2032 has no consensus analysts rating.